The Antibody Society is an international non-profit association representing individuals and organizations involved in antibody research and development. We aim to facilitate discussion and interchange of ideas regarding issues of fundamental importance for basic research, therapeutic development and clinical testing in the field.
To achieve this objective, we serve as Scientific Advisors and Session Chairs for two key meetings, Antibody Engineering & Therapeutics, traditionally held in San Diego, and Antibody Engineering & Therapeutics Europe.
- More information about Antibody Engineering & Therapeutics (US) can be found here.
- More information about Antibody Engineering & Therapeutics Europe can be found here.
As a member of the Federation of Clinical Immunology Societies (FOCIS), we also organize a Symposium held during their annual meeting.
- More information about the Society’s 2018 FOCIS Symposium can be found here.
In addition, our Adaptive Immune Receptor Repertoire (AIRR) Community holds meetings and workshops designed to develop standards and recommendations for: 1) obtaining, analyzing, curating and comparing/sharing NGS AIRR datasets; 2) using and validating tools for analyzing AIRR data; 3) relating AIRR NGS datasets to other “big data” sets, such as microarray, flow cytometric, and MiSeq gene-expression data; and 4) legal and ethical issues involving the use and sharing of AIRR data sets derived from human sources.
- The next AIRR Community meeting will be held May 11-15, 2019, at the University of Genoa Scuola Politecnica, in Genoa, Italy. Session topics include: 1) Advances in Understanding Biological Processes of AIRR; 2) Challenges in Processing and Storing of Massive Datasets (>1bn Sequences); 3) Advances in AIRR-seq Addressing Human Health and Disease; and 4) Challenges in Engaging Stakeholders in the Process of Research and Translation. More information will be posted soon.
The Antibody Engineering & Therapeutics conference and exhibition is our premier forum for scientific exchange and networking in the fields of antibody engineering and therapeutics, immunobiology and next-generation binders. For over 25 years, renowned academic and industry scientists from around the world have convened to share best practices and scientific results to accelerate antibody research, discovery efforts and clinical programs. We look forward to seeing you there!